Finn's Take· TL;DRAs a teenager in Kenya, long before Evelyn Okinyi Owala became a professional bodybuilder, she led a fairly ordinary life — attending school, spending time with friends, and helping her parents around the house. But every month, her period brought something far from ordinary: excruciating pain, vomiting, fever, lightheadedness, heavy bleeding, pelvic pain, and acne. For years, she told no one and sought no help. She believed what so many African women have been taught to believe — that this level of suffering was simply part of being a woman.
Over time, Owala said, the pain grew so severe that she struggled to breathe and passed out. She endured it without seeking medical help because she thought it was normal, and said it grew worse in her 20s. After years of suffering, it wasn't until the age of 30 that Owala finally went to see a gynecologist. What she found out changed her life — and eventually redirected her mission entirely.
Owala discovered she had cysts in her womb. She eventually went for surgery, but they recurred. Rather than surrender to the cycle of pain and treatment, she turned to fitness. She began bodybuilding, and eventually her cysts disappeared. She also changed her diet, eliminating greasy food, processed food, and dairy. The transformation was so profound that it reshaped her entire career and worldview.
Owala traded spreadsheets for squat racks after eight years in commercial banking, entered her first bodybuilding contest in 2016, and rocketed to continental fame by winning both the 2019 Africa Women Bodybuilding Championship and the Arnold Classic Africa. That double victory earned her Kenya's first IFBB Elite Pro Card. Today, Kenyan professional bodybuilder Evelyn Okinyi Owala has made it her life's mission to educate women on reproductive health issues. She has seen clients with fibroids or hormonal imbalances improve through bodybuilding and changes to their diet — something she says makes her work deeply rewarding.
Uterine fibroids are noncancerous growths that develop in or around the uterus, often during a woman's reproductive years. According to the Office on Women's Health at the US Department of Health and Human Services, an estimated 20% to 80% of women develop fibroids by age 50. But across Africa, the crisis is compounded by layers of cultural silence. There are challenges in obtaining a diagnosis — some economic, some behavioral. Sociocultural stigma and financial hardship create a barrier to seeking treatment and management of this chronic disease.
Conversations about menstrual health, heavy bleeding, or fertility are often shrouded in cultural silence. Many women present for care very late, sometimes with very large tumors, increasing the risk of complications. Because fibroids can run in families, symptom normalization may be passed down through generations of women. The result is a quiet epidemic — one where suffering is inherited alongside the silence used to conceal it.
Kenyan-Mexican actress Lupita Nyong'o is among the women who have spoken publicly about the condition. Nyong'o has said she was diagnosed with uterine fibroids after winning an Academy Award for her performance in "12 Years a Slave," and that doctors removed 25 fibroids during one operation — with 77 fibroids over the course of her experience with the condition. When she began to feel her symptoms signaled a deeper issue, Nyong'o brought her concerns to doctors, who regularly dismissed her symptoms as inexplicable or too ambiguous to diagnose. Her story mirrors what countless African women face every day without the platform to say so.
The voices of Owala and Nyong'o are part of a growing chorus demanding that reproductive pain stop being treated as a rite of passage. As advocates put it, women should not have to suffer in silence or wait years before someone finally believes them — and no girl should grow up believing unbearable period pain is simply part of being a woman. With awareness expanding and advocates pushing harder than ever for better access to diagnosis and care across the continent, the conversation is finally beginning to shift. Whether health systems in Africa shift with it remains the defining challenge ahead.